An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education, looks at the impact of a virtual patient simulation focused on secondary prevention of cardiovascular events in a patient with T2D and the use of GLP-1 RAs by endocrinologists and primary care physicians.
The study found that within the simulation, which involved selecting treatment that addresses both glycemic control and cardiovascular event protection, the CME resulted in a 29 percentage point increase in correct decisions from pre to post feedback (40.9% to 69.9%;P< .001).
The study also showed that 24.8% of physicians in the CME group increased their use of guideline-directed treatment for patients with T2D, compared to 12.7% in the matched comparison group.
Being in the intervention group was associated with being 4.2 times more likely (P< .001) to select GLP-1 RA for patients with T2D after education.
Read the full findingsHERE
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programs for physicians, nurses, and other healthcare professionals. Medscape is a subsidiary of WebMD Health Corp.
7th September 2023
Address:
Web M D Global, Kent House
14-17 Market Place
London
W1W 8AJ
United Kingdom
